ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

NCI May Give Up Positions From Other Programs To Meet Mandate For CTP Slots

October 19, 1979

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

In Brief: Oncology Nursing Society Names Board Of Directors

May 16, 2014

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

Loss Of Core Grants Imperials Status Of Three Comprehensive Cancer Centers

July 14, 1989

Blacks Half As Likely To Get Surgery For Esophageal Cancer

January 28, 2005